HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malignant lymphoma presenting as a cardiac tumor and superior vena caval syndrome successfully treated by haploidentical stem cell transplantation.

Abstract
A 16 year-old male with B-cell non-Hodgkin's lymphoma presenting as a cardiac tumor and superior vena caval (SVC) syndrome received a haploidentical stem cell transplant (SCT) from his mother after conventional and salvage chemotherapy. He received additional radiation therapy for the residual tumor and is alive and well on day 640 after transplantation. Malignant lymphoma presenting as a cardiac tumor, including primary cardiac lymphoma, is rare. Although many reports have shown the poor prognosis of cardiac lymphoma, our case suggests that allogeneic haploidentical SCT might be useful for the treatment of aggressive cardiac lymphoma.
AuthorsShin-Ichi Fuchida, Noriko Yamada, Ryo Uchida, Akira Okano, Masashi Okamoto, Naoya Ochiai, Chihiro Shimazaki
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 46 Issue 10 Pg. 1517-21 (Oct 2005) ISSN: 1042-8194 [Print] United States
PMID16194899 (Publication Type: Case Reports, Journal Article)
Topics
  • Adolescent
  • Biopsy
  • Heart Neoplasms (complications, diagnosis, radiotherapy)
  • Humans
  • Lymphoma, B-Cell (drug therapy, pathology, radiotherapy, surgery)
  • Male
  • Stem Cell Transplantation
  • Superior Vena Cava Syndrome (complications, diagnosis, radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: